On the evening of January 7th Beijing time, Jilin Zhengye Biological Products Co., Ltd. (referred to as "Zhengye Biotechnology") successfully went public on the NASDAQ Stock Exchange in the United States, filling the gap for Jilin Province's enterprises to go public in the United States.

Zhengye Biotechnology is an animal vaccine manufacturer whose main business includes research and development, manufacturing, sales, and technical services of animal vaccines. The company is located in Jilin City, Jilin Province, China. Its predecessor was Harbin Veterinary Biopharmaceutical Factory of the Ministry of Agriculture, which relocated to Jilin City in 1970. It is one of the earliest veterinary biopharmaceutical enterprises directly under the Ministry of Agriculture in China, with a history of more than 50 years.

In 2004, Zhengye Biotechnology was restructured from Jilin Province Biological Products Factory and is now a privately-owned joint-stock enterprise. The company's products cover four types of animal vaccines, including pigs, poultry, ruminants, and pets. Its marketing network covers more than 30 provinces, autonomous regions, and municipalities directly under the central government in China. Multiple livestock and poultry vaccine products have been successfully exported to overseas markets, making it the first animal vaccine export enterprise in Jilin Province.

As the first company in Jilin Province to be listed on NASDAQ, Zhengye Biotechnology stated that the successful listing on the US stock market will help the company further expand its scale, enhance its brand value, expand its market and financing channels, and strengthen its international competitiveness. This also marks the beginning of a new chapter in the company's global development.

It is reported that in 2024, under the overall promotion of the Jilin Provincial Party Committee and Provincial Government, the Financial Office of the Jilin Provincial Party Committee actively adapts to the strong regulatory policy of the China Securities Regulatory Commission's IPO, continues to implement the "Jixiang" plan for enterprise listing, and fully promotes enterprise listing.

Next, the Financial Office of the Jilin Provincial Party Committee will continue to improve the level of new quality productivity in capital market services, strive to build a new development pattern of simultaneous domestic and overseas listing, provide strong support for the high-quality development of Jilin's capital market, and promote Jilin's comprehensive revitalization to achieve new breakthroughs first, "said the relevant person in charge of the Financial Office of the Jilin Provincial Party Committee. (Tian Tian)